Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gouttefangeas

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|May 11, 2004
Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004G Pawelec, C Gouttefangeas
Nature Biotechnology|May 10, 2000
Problem solving for tumor immunotherapyC Gouttefangeas, H G Rammensee
Der Urologe. Ausg. A|October 13, 2011
[Prostate carcinoma: vaccination as a new option for treatment]J Bedke, C Gouttefangeas, A Stenzl
Blood|February 15, 1990
Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Cancer Immunology, Immunotherapy : CII|September 30, 2005
Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005C M Britten, C Gouttefangeas, S Kreiter
Cancer Immunology, Immunotherapy : CII|August 12, 2006
CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006C Gouttefangeas, C M Britten, E Derhovanessian Badalians, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2005
Immunosenescence, suppression and tumour progressionG Pawelec, S Koch, H Griesemann, et al.
Leukemia & Lymphoma|July 27, 2016
Identification of CD3 Associated T Cell Receptor as a Diagnostic Tool in T Cell Acute Lymphoblastic Lymphoma or LeukemiaL Boumsell, C Gouttefangeas, H Dastot, et al.
International Immunology|March 1, 1994
Differential proliferative responses in subsets of human CD28+ cells delineated by BB27 mAbC Gouttefangeas, S Jacquot, E Meffre, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|May 11, 2004
Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004G Pawelec, C Gouttefangeas
Nature Biotechnology|May 10, 2000
Problem solving for tumor immunotherapyC Gouttefangeas, H G Rammensee
Der Urologe. Ausg. A|October 13, 2011
[Prostate carcinoma: vaccination as a new option for treatment]J Bedke, C Gouttefangeas, A Stenzl
Blood|February 15, 1990
Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemiaC Gouttefangeas, A Bensussan, L Boumsell
Cancer Immunology, Immunotherapy : CII|September 30, 2005
Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005C M Britten, C Gouttefangeas, S Kreiter
Cancer Immunology, Immunotherapy : CII|August 12, 2006
CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006C Gouttefangeas, C M Britten, E Derhovanessian Badalians, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2005
Immunosenescence, suppression and tumour progressionG Pawelec, S Koch, H Griesemann, et al.
Leukemia & Lymphoma|July 27, 2016
Identification of CD3 Associated T Cell Receptor as a Diagnostic Tool in T Cell Acute Lymphoblastic Lymphoma or LeukemiaL Boumsell, C Gouttefangeas, H Dastot, et al.
International Immunology|March 1, 1994
Differential proliferative responses in subsets of human CD28+ cells delineated by BB27 mAbC Gouttefangeas, S Jacquot, E Meffre, et al.
Pageof 3